OVERVIEW

TB-500 (Thymosin Beta-4) is a synthetic peptide consisting of 43 amino acids, modeled after a naturally occurring protein in the body. It is widely studied for its potential role in tissue repair, regeneration, and healing. Thymosin Beta-4 is involved in cellular migration, angiogenesis (the formation of new blood vessels), and the modulation of inflammatory responses. By supporting these processes, TB-500 has been explored in research for its potential benefits in recovery from muscle, tendon, ligament, and joint injuries. Its mechanism of action also includes promoting the formation of actin filaments, which are essential for cell movement and tissue repair.

TB-500 is typically supplied as a lyophilized powder for research purposes or experimental use. Preclinical and early research studies suggest that it may accelerate recovery, reduce inflammation, and improve flexibility in damaged tissues. While it has shown promise in animal models and limited experimental settings, TB-500 is not approved by major regulatory authorities for general medical use. Potential side effects are considered minimal but may include temporary fatigue or mild fluid retention. Because it is a biologically active peptide that influences repair and regenerative pathways, professional guidance is recommended for dosing, administration, and monitoring during research or experimental applications.